IGC PHARMA INC (IGC)
US45408X3089 - Common Stock
| TTM (2023-12-31) | 2023 (2023-3-31) | 2022 (2022-3-31) | 2021 (2021-3-31) | 2020 (2020-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -14.14M | -11.51M | -15.02M | -8.81M | -7.32M | |||
| Depreciation Amortization | 633.00K | 660.00K | 650.00K | 480.00K | 140.00K | |||
| Income Taxes - Deferred | N/A | N/A | N/A | N/A | N/A | |||
| Change In Working Capital | 1.87M | 790.00K | 2.54M | -3.29M | -3.06M | |||
| Interest Paid | N/A | N/A | 0.00 | 0.00 | 10.00K | |||
| Taxes Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 5.46M | 3.01M | 4.37M | 830.00K | 1.55M | |||
| OPERATING CASH FLOW | -6.19M | -7.05M | -7.46M | -10.80M | -8.68M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -670.00K | -620.00K | -740.00K | -1.59M | -4.47M | |||
| Other Investing Activity | 426.00K | 380.00K | 0.00 | 4.98M | -5.08M | |||
| INVESTING CASH FLOW | -244.00K | -240.00K | -740.00K | 3.39M | -9.55M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -3.00K | 0.00 | 0.00 | -50.00K | 0.00 | |||
| Stock Issued/Repurchased | N/A | 100.00K | 4.15M | 14.74M | -60.00K | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 2.86M | 100.00K | 4.14M | 14.69M | -60.00K | |||
| Exchange Rate Effect | 2.00K | -80.00K | -30.00K | 20.00K | -70.00K | |||
| CHANGE IN CASH | -3.58M | -7.27M | -4.09M | 7.30M | -18.36M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -6.19M | -7.05M | -7.46M | -10.80M | -8.68M | |||
| Capital Expenditure | -670.00K | -620.00K | -740.00K | -1.59M | -4.47M | |||
| FREE CASH FLOW | -6.86M | -7.67M | -8.20M | -12.39M | -13.15M | |||
All data in USD